Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3212]

Drug that targets metabolic vulnerability and impairs cancer cell growth and survival ID'd

Drug that targets metabolic vulnerability and impairs cancer cell growth and survival ID'd

New epigenetic drug against Mantle Cell Lymphoma

New epigenetic drug against Mantle Cell Lymphoma

FDA approves venetoclax for CLL or SLL, with or without 17 p deletion, after one prior therapy

FDA approves venetoclax for CLL or SLL, with or without 17 p deletion, after one prior therapy

Rigorous study finds widely used treatment for infection fails young cancer patients

Rigorous study finds widely used treatment for infection fails young cancer patients

Study of acute myeloid leukemia patients shows protein inhibitor drug safe and effective with durable remissions

Study of acute myeloid leukemia patients shows protein inhibitor drug safe and effective with durable remissions

Increase in lifestyle-related cancers over past decade spotlights need for prevention

Increase in lifestyle-related cancers over past decade spotlights need for prevention

Phase I trial finds experimental drug safe in treating chronic lymphocytic leukaemia

Phase I trial finds experimental drug safe in treating chronic lymphocytic leukaemia

Lipid molecules can be used for cancer growth

Lipid molecules can be used for cancer growth

Researchers find leukaemia and lymphoma drug may benefit glioblastoma patients

Researchers find leukaemia and lymphoma drug may benefit glioblastoma patients

Two-pronged antibodies draw immune killers directly to cancer cells

Two-pronged antibodies draw immune killers directly to cancer cells

More from ecancer